Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eniluracil (GW776C85) is an orally activedihydropyrimidine dehydrogenase (DPD) inhibitor,increases the oral bioavailability of 5-FU to 100%, facilitating uniform absorption and predictable toxicity.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 9,500 | |||
25 mg | 在庫あり | ¥ 17,500 | |||
50 mg | 在庫あり | ¥ 28,500 | |||
100 mg | 在庫あり | ¥ 42,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,500 |
説明 | Eniluracil (GW776C85) is an orally activedihydropyrimidine dehydrogenase (DPD) inhibitor,increases the oral bioavailability of 5-FU to 100%, facilitating uniform absorption and predictable toxicity. |
別名 | GW776C85, 5-Ethynyluracil |
分子量 | 136.11 |
分子式 | C6H4N2O2 |
CAS No. | 59989-18-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 62.5 mg/mL (459.19 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eniluracil 59989-18-3 Others 5-fluorouracil cancer Inhibitor inhibit GW776C85 5-FU 5-Ethynyluracil tumor combination inhibitor